Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Robert Marek Mróz"'
Autor:
Katarzyna Guziejko, Łukasz Minarowski, Agata Piłaszewicz-Puza, Anna Szumera-Ciećkiewicz, Robert Marek Mróz
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-7 (2022)
Sarcoidosis is an inflammatory, multisystem disease with an undetermined etiology. The presence of noncaseating granulomas in involved organs is a characteristic pathomorphological feature. Sarcoidosis, like a chameleon, can mimic different medical c
Externí odkaz:
https://doaj.org/article/d6b1502a02fb468880330cc38f363cab
Publikováno v:
Contemporary Oncology, Vol 25, Iss 1, Pp 53-56 (2021)
Immunotherapy is a new and very promising method of anti-cancer treatment. Unfortunately, not every patient can benefit from this treatment. The Polish drug program determines the selection of patients based on PD-L1 expression and the performanc
Externí odkaz:
https://doaj.org/article/33951a72defa418a95258e7273536311
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Background: Chronic pulmonary aspergillosis (CPA) is a rare complication of radiochemotherapy for lung cancer. It may develop months or years after radical treatment. The diagnosis of CPA is challenging and complex. Not only fungal infection but also
Externí odkaz:
https://doaj.org/article/098bcb92a6df4de58e48639066e76f26
Publikováno v:
American Journal of Case Reports. 23
BACKGROUND Atezolizumab is an immune checkpoint inhibitor used as first-line treatment with carboplatin and etoposide chemotherapy for advanced small cell lung cancer. Immunochemotherapy treatment decisions can be affected by patients' physical abili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::916ecaabc0c858aaee0a900e79bae28b
https://doi.org/10.12659/ajcr.936536
https://doi.org/10.12659/ajcr.936536
Autor:
Damian Mojsak, Michał Dębczyński, Beata Kuklińska, Anna Moniuszko-Malinowska, Robert Marek Mróz
Publikováno v:
American Journal of Case Reports. 23
BACKGROUND Advanced non-small cell lung cancer has poor prognosis and low survival. Immunotherapy with the use of immune checkpoint inhibitors is a relatively new method of treatment that offers a chance to significantly extend the survival and quali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8533703eeb419e126f5bba841ac7d143
https://doi.org/10.12659/ajcr.936420
https://doi.org/10.12659/ajcr.936420
Autor:
Damian Mojsak, Michał Dębczyński, Beata Kuklińska, Łukasz Minarowski, Agnieszka Kasiukiewicz, Anna Moniuszko-Malinowska, Piotr Czupryna, Robert Marek Mróz
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 20; Issue 2; Pages: 1583
The COVID-19 pandemic poses a challenge to health systems worldwide. Limiting healthcare availability may delay early diagnosis and worsen the treatment effects of various diseases, including oncological diseases. We analyzed patients presenting to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a819d6f3661fc54770798260d34747d
https://doi.org/10.3390/ijerph20021583
https://doi.org/10.3390/ijerph20021583
Autor:
Robert Marek, Mróz, Jacek, Noparlik, Elzbieta, Chyczewska, Jan Józef, Braszko, Adam, Hołownia
Publikováno v:
Pneumonologia i alergologia polska. 75(4)
Chronic obstructive pulmonary disease (COPD) is a 4(th) major cause of morbidity and mortality worldwide. Cigarette smoking and oxidative/nitrosative stress leading to chronic inflammation is considered as a major cause of COPD but up to now, details
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9579cce151c07840a118efb2ae56f234
https://pubmed.ncbi.nlm.nih.gov/18080988
https://pubmed.ncbi.nlm.nih.gov/18080988
[Posttranslational p53 phosphorylation in non small cell lung cancer cells after radio/chemotherapy]
Autor:
Adam, Hołownia, Robert Marek, Mróz, Mirosław, Kozłowski, Elzbieta, Chyczewska, Jerzy, Laudański, Lech, Chyczewski, Jan Józef, Braszko
Publikováno v:
Pneumonologia i alergologia polska. 75(3)
p53 protein is a critical regulator of cell cycle and apoptosis. Many stimuli change its expression and modify its functions. The aim of our work was to determine stability and chosen posttranslational modification of p53 protein during the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da89323f3945472fccfcbe9c1470f184
https://pubmed.ncbi.nlm.nih.gov/17966099
https://pubmed.ncbi.nlm.nih.gov/17966099